Your browser doesn't support javascript.
loading
Performance comparison of high throughput single-cell RNA-Seq platforms in complex tissues.
Colino-Sanguino, Yolanda; Rodriguez de la Fuente, Laura; Gloss, Brian; Law, Andrew M K; Handler, Kristina; Pajic, Marina; Salomon, Robert; Gallego-Ortega, David; Valdes-Mora, Fatima.
Afiliação
  • Colino-Sanguino Y; Cancer Epigenetic Biology and Therapeutics Laboratory, Children's Cancer Institute, Lowy Cancer Centre, Kensington, NSW, Australia.
  • Rodriguez de la Fuente L; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, NSW, Australia.
  • Gloss B; Cancer Epigenetic Biology and Therapeutics Laboratory, Children's Cancer Institute, Lowy Cancer Centre, Kensington, NSW, Australia.
  • Law AMK; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, NSW, Australia.
  • Handler K; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
  • Pajic M; School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, NSW, Australia.
  • Salomon R; Westmead Research Hub, Westmead Institute for Medical Research, Sydney, NSW, Australia.
  • Gallego-Ortega D; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales Sydney, NSW, Australia.
  • Valdes-Mora F; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Heliyon ; 10(17): e37185, 2024 Sep 15.
Article em En | MEDLINE | ID: mdl-39296129
ABSTRACT
Single-cell transcriptomics has emerged as the preferred tool to define cell identity through the analysis of gene expression signatures. However, there are limited studies that have comprehensively compared the performance of different scRNAseq systems in complex tissues. Here, we present a systematic comparison of two well-established high throughput 3'-scRNAseq platforms 10× Chromium and BD Rhapsody, using tumours that present high cell diversity. Our experimental design includes both fresh and artificially damaged samples from the same tumours, which also provides a comparable dataset to examine their performance under challenging conditions. The performance metrics used in this study consist of gene sensitivity, mitochondrial content, reproducibility, clustering capabilities, cell type representation and ambient RNA contamination. These analyses showed that BD Rhapsody and 10× Chromium have similar gene sensitivity, while BD Rhapsody has the highest mitochondrial content. Interestingly, we found cell type detection biases between platforms, including a lower proportion of endothelial and myofibroblast cells in BD Rhapsody and lower gene sensitivity in granulocytes for 10× Chromium. Moreover, the source of the ambient noise was different between plate-based and droplet-based platforms. In conclusion, our reported platform differential performance should be considered for the selection of the scRNAseq method during the study experimental designs.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article